List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 245 studies with search of:   "Genzyme" [Exact]
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Terminated A Safety and Efficacy Study of DENSPM in Patients With Liver Cancer Who Are Not Eligible for Surgical Care
Condition: Carcinoma, Hepatocellular
Intervention: Drug: DENSPM (diethylnorspermine)
2 Completed A Study of the Safety and Efficacy of Synvisc in Patients With Symptomatic Shoulder Osteoarthritis
Conditions: Osteoarthritis;   Musculoskeletal Diseases
Intervention: Device: Synvisc (hylan G-F 20)
3 Completed A Placebo-Controlled Study of Safety and Effectiveness of Myozyme in Patients With Late-Onset Pompe Disease
Conditions: Pompe Disease (Late-Onset);   Glycogen Storage Disease Type II (GSD-II);   Acid Maltase Deficiency Disease;   Glycogenosis 2
Interventions: Drug: Myozyme (alglucosidase alfa);   Drug: Placebo
4 Recruiting Pompe Disease Registry
Conditions: Glycogen Storage Disease Type II;   Pompe Disease
Intervention:
5 Completed An Open-Label, Prospective, Randomized, Multi-Center, Phase II Comparative Trial of Thymoglobulin Versus Simulect for the Prevention of Delayed Graft Function and Acute Allograft Rejection in Renal Allograft Recipients.
Conditions: Cadaveric Donor Renal Transplantation;   Acute Renal Allograft Rejection;   Induction Therapy
Intervention: Drug: Thymoglobulin [Anti-thymocyte Globulin (rabbit)]
6 Completed A Phase 4, Conversion Study of Hectorol® Injection to Hectorol® Capsules in Stage 5 CKD Patients on Dialysis
Condition: Secondary Hyperparathyroidism
Interventions: Drug: Hectorol® (doxercalciferol capsules);   Drug: doxercalciferol capsules, Hectorol®;   Drug: doxercalciferol capsules, Hectorol® capsules
7 Terminated Phase I/II Study of CAMPATH in Patients With Relapsing or Refractory Non-Hodgkin's Lymphoma
Condition: Non-Hodgkins Lymphoma
Intervention: Drug: alemtuzumab
8 Suspended A Study of AMD11070 in HIV-Infected Patients Carrying X4-Tropic Virus
Conditions: HIV Infections;   X4 Tropic Virus
Intervention: Drug: AMD11070
9 Completed AMD3100 Added to a Mobilizing Regimen of G-CSF to Increase the Number of PBSCs in Patients With Hodgkin's Disease
Condition: Hodgkin's Disease
Intervention: Drug: AMD3100
10 Recruiting Immune Tolerance Induction Study
Conditions: Pompe Disease;   Glycogen Storage Disease Type II (GSD II);   Glycogenesis 2 Acid Maltase Deficiency
Interventions: Biological: Alglucosidase alfa;   Biological: Alglucosidase alfa
11 Completed Safety, PK, And Hematological Activity Of AMD3100 In Subjects With Renal Impairment
Condition: Renal Impairment
Intervention: Drug: AMD3100
12 No longer available This is a Multi-Center, Single Arm, Open Label Study Intended to Provide Expanded Access to Plerixafor for Patients With Non-Hodgkin's Lymphoma (NHL), Hodgkin's Disease (HD) or Multiple Myeloma (MM) Who Are to Receive Treatment With an Autologous Peripheral Stem Cell Transplant.
Conditions: Non-Hodgkin's Lymphoma;   Hodgkin's Disease;   Multiple Myeloma
Intervention: Drug: Plerixafor
13 Completed A Study of the Absorption of GT267-004 in Patients With Clostridium Difficile-Associated Diarrhea
Conditions: Pseudomembranous Colitis;   Clostridium Difficile Diarrhea;   Antibiotic-Associated Diarrhea
Intervention: Drug: tolevamer potassium-sodium (GT267-004)
14 Active, not recruiting Aminopterin in Treating Patients With Refractory Leukemia
Condition: Leukemia
Interventions: Drug: aminopterin;   Drug: leucovorin calcium
15 Recruiting A Study of Clofarabine in Combination With Etoposide and Cyclophosphamide in Children With Acute Leukemias.
Conditions: Acute Lymphoblastic Leukemia;   Acute Myelogenous Leukemia;   Relapsed Leukemia
Intervention: Drug: clofarabine (IV formulation), etoposide, cyclophosphamide
16 Recruiting Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study Two
Condition: Multiple Sclerosis, Relapsing-Remitting
Interventions: Biological: alemtuzumab;   Biological: alemtuzumab;   Biological: interferon beta-1a (Rebif®)
17 Completed Safety, Tolerability, and Pharmacokinetics of CAT-192 (Human Anti-TGF-Beta1 Monoclonal Antibody) in Patients With Early Stage Diffuse Systemic Sclerosis
Conditions: Systemic Sclerosis;   Scleroderma
Intervention: Drug: Human Anti-Transforming Growth Factor Beta-1 Monoclonal Antibody
18 Recruiting A Study of the Effects of Fabrazyme on Mother's Lactation and on the Growth, Development and Immunologic Response of Their Infants
Condition: Fabry Disease
Intervention: Drug: Fabrazyme (agalsidase beta)
19 Active, not recruiting A Study to Evaluate the Safety and Effectiveness of Doxercalciferol Capsules in Patients With Moderate to Severe Psoriasis
Condition: Moderate to Severe Chronic Plaque Psoriasis
Interventions: Drug: doxercalciferol;   Drug: doxercalciferol;   Drug: doxercalciferol;   Other: N/A - placebo
20 Terminated Efficacy of Seprapack Sinus Dressing Versus No Dressing in the Prevention of Intranasal Adhesions Following Sinus Surgery
Condition: Chronic Sinusitus
Intervention: Device: Seprapack Sinus Dressing

Previous Page Studies Shown (1-20) Next (21-40)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services